The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.

The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.

Dettagli Bibliografici
Autori principali:	Trivellin, G, Bolger, G, Igreja, S, Chahal, H, Grossman, AB, Korbonits, M
Natura:	Conference item
Pubblicazione:	2010

Documenti analoghi

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
di: Igreja, S, et al.
Pubblicazione: (2010)

AIP mutation in pituitary adenomas in the 18th century and today.
di: Chahal, H, et al.
Pubblicazione: (2011)

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
di: Chahal, H, et al.
Pubblicazione: (2011)

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
di: Chahal, H, et al.
Pubblicazione: (2012)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
di: Preda, V, et al.
Pubblicazione: (2014)

MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
di: Trivellin, G, et al.
Pubblicazione: (2012)

Oncogene-induced senescence in pituitary adenomas and carcinomas.
di: Alexandraki, K, et al.
Pubblicazione: (2012)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in an AIP Mutation-Positive Family
di: Pedro Marques, et al.
Pubblicazione: (2018-01-01)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
di: Adrian F Daly, et al.
Pubblicazione: (2019-03-01)

Metabolic changes in patients with familial pituitary adenomas associated with mutations in the AIP gene
di: Tatiana S. Tarasova, et al.
Pubblicazione: (2017-03-01)

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
di: Chahal, H, et al.
Pubblicazione: (2010)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
di: Lloyd, C, et al.
Pubblicazione: (2014)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas
di: Lloyd, C, et al.
Pubblicazione: (2014)

A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
di: Ewing, I, et al.
Pubblicazione: (2007)

Novel molecular aspects of pituitary adenomas.
di: Hubina, E, et al.
Pubblicazione: (2005)

The pathology of pituitary adenomas from a clinical perspective.
di: Dworakowska, D, et al.
Pubblicazione: (2011)

The pathophysiology of pituitary adenomas.
di: Dworakowska, D, et al.
Pubblicazione: (2009)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
di: Morris, D, et al.
Pubblicazione: (2005)

Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
di: Garcia, E, et al.
Pubblicazione: (2013)

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
di: Igreja, S, et al.
Pubblicazione: (2009)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
di: Chahal, H, et al.
Pubblicazione: (2010)

Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
di: Vax, V, et al.
Pubblicazione: (2003)

Akting and cycling: a tale of the pituitary.
di: Grossman, AB, et al.
Pubblicazione: (2004)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
di: Korbonits, M, et al.
Pubblicazione: (1998)

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
di: Morris, D, et al.
Pubblicazione: (2003)

The release of leptin and its effect on hormone release from human pituitary adenomas.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
di: Dworakowska, D, et al.
Pubblicazione: (2009)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
di: Chahal, H, et al.
Pubblicazione: (2011)

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma.
di: Allan, C, et al.
Pubblicazione: (2001)

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism
di: Syed Ali Imran, et al.
Pubblicazione: (2018-01-01)

Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
di: Pyle, M, et al.
Pubblicazione: (2003)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
di: Korbonits, M, et al.
Pubblicazione: (1999)

Pituitary adenoma: important genetic factors and clinical diagnostic issues
di: G. Juknytė, et al.
Pubblicazione: (2021-06-01)

Second brain tumour after treatment for pituitary adenoma.
di: Wass, J, et al.
Pubblicazione: (1992)

Cyclins and their related proteins in pituitary tumourigenesis.
di: Muşat, M, et al.
Pubblicazione: (2010)

Clinical case seminar - Pituitary chondrosarcoma: An unusual cause of a sellar mass presenting as a pituitary adenoma
di: Allan, C, et al.
Pubblicazione: (2001)

Presence of ghrelin in normal and adenomatous human pituitary.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
di: David Netuka, et al.
Pubblicazione: (2022-01-01)

Pituitary adenoma surgery survey: neurosurgical centers and pituitary adenomas
di: D. Netuka, et al.
Pubblicazione: (2022-01-01)